Search

everythinglearnresearchcommunity

for

Search:↓

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

Measuring minimal residual disease on day 15 helps identify high-risk leukemia patients.

Oral tofacitinib successfully treated a girl's severe skin and hair conditions.

Tadalafil and Finasteride may help treat aggressive melanoma.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Sorafenib can cause a unique skin reaction.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Stopping gefitinib improved scalp condition in a woman with lung cancer.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

T cell subsets are crucial in kidney cancer, and a new model predicts patient outcomes using key genes.

Inactivating both p53 and Rb genes in mice speeds up aggressive skin cancer development.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

B cells can both help and hinder the body's defense against melanoma.

Stopping TNFα inhibitors can help children regrow hair lost due to the medication.

Alitretinoin may help treat alopecia areata.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

Bicalutamide may be a promising alternative treatment for female pattern hair loss.

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.

Pulsed electric field treatment may help shrink untreated liver tumors.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.